Patent Description:
Prosthetic heart valves that are collapsible to a relatively small circumferential size can be delivered into a patient less invasively than valves that are not collapsible. For example, a collapsible valve may be delivered into a patient via a tube-like delivery apparatus such as a catheter, a trocar, a laparoscopic instrument, or the like. This collapsibility can avoid the need for a more invasive procedure such as full open-chest, open-heart surgery.

Collapsible prosthetic heart valves typically take the form of a valve structure mounted on a stent. There are two common types of stents on which the valve structures are ordinarily mounted: a self-expanding stent or a balloon-expandable stent. To place such valves into a delivery apparatus and ultimately into a patient, the valve must first be collapsed or crimped to reduce its circumferential size.

When a collapsed prosthetic valve has reached the desired implant site in the patient (e.g., at or near the annulus of the patient's heart valve that is to be replaced by the prosthetic valve), the prosthetic valve can be deployed or released from the delivery apparatus and re-expanded to full operating size. For balloon-expandable valves, this generally involves releasing the entire valve, and then expanding a balloon positioned within the valve stent. For self-expanding valves, on the other hand, the stent automatically expands as the sheath covering the valve is withdrawn.

Prosthetic heart valves with features to prevent paravalvular leakage are known e.g. from <CIT>, <CIT>, <CIT>, <CIT>, <CIT>, <CIT>.

Aspects of the invention are set out in accordance with the appended claims. Embodiments not falling within the scope of the claims are provided for illustrative purposes. In some embodiments, a prosthetic heart valve for replacing a native valve includes a collapsible and expandable stent having a proximal end and a distal end, a valve assembly disposed within the stent, the valve assembly including a plurality of leaflets and a plurality of elongated legs, each of the legs having a first end coupled to the stent and a second free end, the elongated legs being configured to transition from an extended configuration to a relaxed configuration. The heart valve may further include a sealing portion connected to the plurality of legs, the sealing portion forming a sealing structure upon the transition of the plurality of legs from the extended configuration to the relaxed configuration.

In some illustrative examples a method for implanting a prosthetic heart valve in a native valve annulus may include loading the heart valve in a delivery system, the heart valve including: (a) a collapsible and expandable stent having a proximal end and a distal end, (b) a valve assembly disposed within the stent, the valve assembly including a plurality of leaflets, (c) a plurality of elongated legs configured to transition from an extended configuration to a relaxed configuration, and (d) a sealing portion connected to the plurality of legs, the heart valve being loaded in the delivery system with the plurality of legs in the extended configuration. The method may further include delivering the heart valve to the native valve annulus and deploying the heart valve within the native valve annulus, whereupon the plurality of legs transition from the extended configuration to the relaxed configuration and the sealing portion forms a sealing structure.

Various embodiments of the present invention will now be described with reference to the appended drawings. It is to be appreciated that these drawings depict only some embodiments of the invention and are therefore not to be considered limiting of its scope.

Despite the various improvements that have been made to the collapsible prosthetic heart valve delivery process, conventional devices suffer from some shortcomings. For example, with conventional self expanding valves, clinical success of the valve is dependent on accurate deployment and anchoring. Inaccurate deployment and anchoring of the valve increases risks, such as those associated with valve migration, which may cause severe complications and possibly death due to the obstruction of the left ventricular outflow tract. Inaccurate deployment and anchoring may also result in the leakage of blood between the implanted heart valve and the native valve annulus, commonly referred to as perivalvular leakage (also known as "paravalvular leakage"). In aortic valves, this leakage enables blood to flow from the aorta back into the left ventricle, reducing cardiac efficiency and putting a greater strain on the heart muscle. Additionally, calcification of the aortic valve may affect performance and the interaction between the implanted valve and the calcified tissue is believed to be relevant to leakage, as will be outlined below.

Moreover, anatomical variations from one patient to another may cause a fully deployed heart valve to function improperly, requiring removal of the valve from the patient. Removing a fully deployed heart valve increases the length of the procedure as well as the risk of infection and/or damage to heart tissue. Thus, methods and devices are desirable that would reduce the need to remove a prosthetic heart valve from a patient. Methods and devices are also desirable that would reduce the likelihood of perivalvular leakage due to gaps between the implanted heart valve and patient tissue.

There therefore is a need for further improvements to the devices, systems, and methods for transcatheter delivery and positioning of collapsible prosthetic heart valves. Specifically, there is a need for further improvements to the devices, systems, and methods for accurately implanting a prosthetic heart valve. Among other advantages, the present disclosure may address one or more of these needs.

As used herein, the term "proximal," when used in connection with a prosthetic heart valve, refers to the end of the heart valve closest to the heart when the heart valve is implanted in a patient, whereas the term "distal," when used in connection with a prosthetic heart valve, refers to the end of the heart valve farthest from the heart when the heart valve is implanted in a patient. When used in connection with devices for delivering a prosthetic heart valve or other medical device into a patient, the terms "trailing" and "leading" are to be taken as relative to the user of the delivery devices. "Trailing" is to be understood as relatively close to the user, and "leading" is to be understood as relatively farther away from the user.

The sealing portions of the present disclosure may be used in connection with collapsible prosthetic heart valves. <FIG> shows one such collapsible stent-supported prosthetic heart valve <NUM> including a stent <NUM> and a valve assembly <NUM> as is known in the art. The prosthetic heart valve <NUM> is designed to replace a native tricuspid valve of a patient, such as a native aortic valve. It should be noted that while the inventions herein are described predominately in connection with their use with a prosthetic aortic valve and a stent having a shape as illustrated in <FIG>, the valve could be a bicuspid valve, such as the mitral valve, and the stent could have different shapes, such as a flared or conical annulus section, a less-bulbous aortic section, and the like, and a differently shaped transition section.

Prosthetic heart valve <NUM> will be described in more detail with reference to <FIG>. Prosthetic heart valve <NUM> includes expandable stent <NUM> which may be formed from biocompatible materials that are capable of self-expansion, such as, for example, shape memory alloys, such as the nickeltitanium alloy known as "Nitinol" or other suitable metals or polymers. Stent <NUM> extends from proximal or annulus end <NUM> to a distal or aortic end <NUM>, and includes annulus section <NUM> adjacent proximal end <NUM>, transition section <NUM> and aortic section <NUM> adjacent distal end <NUM>. Annulus section <NUM> has a relatively small cross-section in the expanded condition, while aortic section <NUM> has a relatively large cross-section in the expanded condition. Preferably, annulus section <NUM> is in the form of a cylinder having a substantially constant diameter along its length. Transition section <NUM> may taper outwardly from annulus section <NUM> to aortic section <NUM>. Each of the sections of stent <NUM> includes a plurality of struts <NUM> forming cells <NUM> connected to one another in one or more annular rows around the stent. For example, as shown in <FIG>, annulus section <NUM> may have two annular rows of complete cells <NUM> and aortic section <NUM> and transition section <NUM> may each have one or more annular rows of partial cells <NUM>. Cells <NUM> in aortic section <NUM> may be larger than cells <NUM> in annulus section <NUM>. The larger cells in aortic section <NUM> better enable prosthetic valve <NUM> to be positioned in the native valve annulus without the stent structure interfering with blood flow to the coronary arteries.

Stent <NUM> may include one or more retaining elements <NUM> at distal end <NUM> thereof, retaining elements <NUM> being sized and shaped to cooperate with female retaining structures (not shown) provided on the deployment device. The engagement of retaining elements <NUM> with the female retaining structures on the deployment device helps maintain prosthetic heart valve <NUM> in assembled relationship with the deployment device, minimizes longitudinal movement of the prosthetic heart valve relative to the deployment device during unsheathing or resheathing procedures, and helps prevent rotation of the prosthetic heart valve relative to the deployment device as the deployment device is advanced to the target location and the heart valve deployed.

Prosthetic heart valve <NUM> includes valve assembly <NUM> preferably positioned in annulus section <NUM> of the stent <NUM> and secured to the stent. Valve assembly <NUM> includes cuff <NUM> and a plurality of leaflets <NUM> which collectively function as a one-way valve by coapting with one another. As a prosthetic aortic valve, valve <NUM> has three leaflets <NUM>. However, it will be appreciated that other prosthetic heart valves with which the sealing portions of the present disclosure may be used may have a greater or lesser number of leaflets <NUM>.

Although cuff <NUM> is shown in <FIG> as being disposed on the luminal or inner surface of annulus section <NUM>, it is contemplated that cuff <NUM> may be disposed on the abluminal or outer surface of annulus section <NUM> or may cover all or part of either or both of the luminal and abluminal surfaces. Both cuff <NUM> and leaflets <NUM> may be wholly or partly formed of any suitable biological material or polymer such as, for example, polytetrafluoroethylene (PTFE).

Leaflets <NUM> may be attached along their belly portions to cells <NUM> of stent <NUM>, with the commissure between adjacent leaflets <NUM> attached to commissure features <NUM>. As can be seen in <FIG>, each commissure feature <NUM> may lie at the intersection of four cells <NUM>, two of the cells being adjacent one another in the same annular row, and the other two cells being in different annular rows and lying in end-to-end relationship. Preferably, commissure features <NUM> are positioned entirely within annulus section <NUM> or at the juncture of annulus section <NUM> and transition section <NUM>. Commissure features <NUM> may include one or more eyelets which facilitate the suturing of the leaflet commissure to stent <NUM>.

Prosthetic heart valve <NUM> may be used to replace a native aortic valve, a surgical heart valve or a heart valve that has undergone a surgical procedure. Prosthetic heart valve <NUM> may be delivered to the desired site (e.g., near the native aortic annulus) using any suitable delivery device. During delivery, prosthetic heart valve <NUM> is disposed inside the delivery device in the collapsed condition. The delivery device may be introduced into a patient using a transfemoral, transapical, transseptal or any other percutaneous approach. Once the delivery device has reached the target site, the user may deploy prosthetic heart valve <NUM>. Upon deployment, prosthetic heart valve <NUM> expands so that annulus section <NUM> is in secure engagement within the native aortic annulus. When prosthetic heart valve <NUM> is properly positioned inside the heart, it works as a one-way valve, allowing blood to flow from the left ventricle of the heart to the aorta, and preventing blood from flowing in the opposite direction.

Problems may be encountered when implanting prosthetic heart valve <NUM>. For example, in certain procedures, collapsible valves may be implanted in a native valve annulus without first resecting the native valve leaflets. The collapsible valves may have critical clinical issues because of the nature of the stenotic leaflets that are left in place. Additionally, patients with uneven calcification, bi-cuspid aortic valve disease, and/or valve insufficiency cannot be treated well, if at all, with the current collapsible valve designs.

The reliance on unevenly calcified leaflets for proper valve placement and seating could lead to several problems, such as perivalvular leakage (PV leak), which can have severe adverse clinical outcomes. To reduce these adverse events, the optimal valve would anchor adequately and seal without the need for excessive radial force that could harm nearby anatomy and physiology.

<FIG> is a highly schematic cross-sectional illustration of prosthetic heart valve <NUM> disposed within native valve annulus <NUM>. As seen in the figure, valve assembly <NUM> has a substantially circular cross-section which is disposed within the non-circular native valve annulus <NUM>. At certain locations around the perimeter of heart valve <NUM>, gaps <NUM> form between heart valve <NUM> and native valve annulus <NUM>. Blood flowing through these gaps and past valve assembly <NUM> of prosthetic heart valve <NUM> can cause regurgitation and other inefficiencies which reduce cardiac performance. Such improper fitment may be due to suboptimal native valve annulus geometry due, for example, to calcification of native valve annulus <NUM> or to unresected native leaflets.

<FIG> illustrate one embodiment of heart valve <NUM> intended to fill the irregularities between the heart valve and native valve annulus <NUM> shown in <FIG>. Heart valve <NUM> extends between proximal end <NUM> and distal end <NUM>, and may generally include stent <NUM> and valve assembly <NUM> having a plurality of leaflets <NUM> and cuff <NUM>. Heart valve <NUM> may be formed of any of the materials and in any of the configurations described above with reference to <FIG>.

Additionally, heart valve <NUM> may include a number of elongated legs <NUM> and a sealing portion <NUM> coupled to the elongated legs via eyelets <NUM> to mitigate perivalvular leakage. Attachment ends <NUM> of elongated legs <NUM> may be affixed to stent <NUM> near the proximal end <NUM> of heart valve <NUM>, and legs <NUM> may extend away from the distal end <NUM> of stent <NUM> and terminate at free ends <NUM>, which are unattached and free to move. As will be shown in subsequent examples, elongated legs <NUM> may instead be oriented in the opposition direction, being affixed near the proximal end <NUM> of heart valve <NUM> and extending toward the distal end <NUM> of the heart valve. Attachment ends <NUM> of elongated legs <NUM> may be affixed to stent <NUM> using welding, adhesive, or any other suitable technique known in the art. Additionally, legs <NUM> may be formed of a shape memory material such as those described above for forming stent <NUM> of <FIG>, and may have an extended configuration and a relaxed configuration. In the extended configuration, shown in <FIG>, elongated legs <NUM> may be substantially linear. Moreover, instead of being separately formed and affixed to stent <NUM> at attachment ends <NUM>, elongated legs <NUM> may be integrally formed with stent <NUM>, such as by laser cutting both stent <NUM> and elongated legs <NUM> from the same tube.

Sealing portion <NUM> may be attached to legs <NUM> to form a cylindrical tube around the interior or exterior of the legs. Sealing portion <NUM> may be attached to legs <NUM> via sutures, adhesive or any other suitable method. For example, each leg <NUM> may include eyelets <NUM> and sealing portion <NUM> may be attached to eyelets <NUM> via sutures (not shown). Where eyelets <NUM> are provided in this or any of the other embodiments described herein, they may be disposed at the free ends of legs <NUM> as illustrated in <FIG>, or anywhere else along the length of the legs. Providing eyelets <NUM> along the length of legs <NUM> may better hold sealing portion <NUM> to the legs as the legs move between their extended and relaxed configurations. Moreover, it will be understood that other features such as indentations or notches may be used to couple two portions of the prosthetic valve using sutures.

Sealing portion <NUM> may be formed of the same material as cuff <NUM>, including natural materials such as, for example, bovine or porcine pericardium, or synthetic materials such as, for example, ultra-high-molecular-weight polyethylene (UHMWPE), or combinations thereof. In one example, sealing portion <NUM> may be formed by increasing the length of cuff <NUM> and extending it over the proximal end <NUM> and legs <NUM> of heart valve <NUM>. Alternatively, sealing portion <NUM> may be formed separately from cuff <NUM> and attached to eyelets <NUM> at the proximal end <NUM> of heart valve <NUM> to form a seam with cuff <NUM>.

In a variant of the foregoing, sealing portion <NUM> of heart valve <NUM> may be formed from a tubular section of braided fabric comprising a plurality of braided strands. The strands forming the braid may have a predetermined relative orientation with respect to one another (e.g., a helical braid). Moreover, sealing portion <NUM> may comprise a plurality of layers of braided fabric and/or other occluding material such that sealing portion <NUM> is capable of at least partially inhibiting blood flow therethrough in order to promote the formation of thrombus, endothelialization and epithelialization.

In such variants, sealing portion <NUM> may be formed of a passive material (e.g., one that does not change shape in response to a stimulus) so that it simply conforms to the shape of legs <NUM>. Alternatively, sealing portion <NUM> may be formed, for example, of a braided fabric mesh of a shape-memory material, of a super-elastic material, of a bio-compatible polymer, or of another material that is capable of being actuated between an extended configuration and a relaxed configuration. Sealing portion <NUM> may comprise a braided metal fabric that is both resilient and capable of heat treatment to substantially set a desired shape (e.g., the relaxed configuration shown in <FIG>). One class of materials which meets these qualifications is shape memory alloys, such as Nitinol. It is also understood that sealing portion <NUM> may comprise various materials other than Nitinol that have elastic and/or memory properties, such as spring stainless steel, trade named alloys such as Elgiloy®, Hastelloy®, CoCrNi alloys (e.g., trade name Phynox), MP35N®, CoCrMo alloys, mixtures of such alloys or mixtures of metal and polymer fibers. Depending on the individual material selected, the strand diameter, number of strands, and pitch may be altered to achieve the desired properties for sealing portion <NUM>. Thus, sealing portion <NUM> may alternate between the extended configuration and the relaxed configuration due to the changing shape of legs <NUM> or alternatively it may itself alternate between the two configurations due to its own shape-memory material properties.

<FIG> illustrates the relaxed configuration of heart valve <NUM>. As noted above, legs <NUM> may have an extended configuration and a relaxed configuration. To effectuate this change in configuration, legs <NUM> may be curled and subjected to a heat setting process. This process may be accomplished in a series of steps. For example, legs <NUM> may be formed with a first curl and heat set, and then formed with a second curl and further heat set. The relaxed configuration of legs <NUM> may therefore include multiple curls due to the curling and heat setting process described above. Legs <NUM> may be straightened to the extended configuration (shown in <FIG> and described above) for cooperation with a delivery system as will be described below with reference to <FIG>, and may return to the curled, relaxed configuration after removal from the delivery system. As shown in <FIG>, when heart valve <NUM> is permitted to return to its relaxed configuration, legs <NUM> may curl up toward distal end <NUM> and pull sealing portion <NUM> with them, rolling sealing portion <NUM> up in the process to form sealing ring <NUM> at proximal end <NUM> of heart valve <NUM>. Sealing ring <NUM> may have a radius larger than that of valve assembly <NUM>, the larger radius of sealing ring <NUM> being capable of filling any gaps between heart valve <NUM> and the native valve annulus (not shown). The length of sealing ring <NUM> may depend on the number of curls of legs <NUM>. For example, sealing ring <NUM> may have a length that is approximately onehalf of the length of legs <NUM>. As shown in <FIG>, sealing ring <NUM> is formed below proximal end <NUM> and may be suitable for a sub-leaflet application as will be described in greater detail below with reference to <FIG>. Sealing ring <NUM> may be readily deformable to conform to the shape of the native valve annulus, portions of sealing ring <NUM> being configured to compress when pressed against the walls of the native valve annulus and other portions of sealing ring <NUM> being configured to radially expand in gaps, thereby filling the gaps between heart valve <NUM> and the native valve annulus.

A method of delivering and implanting heart valve <NUM> will now be described with reference to <FIG>. A delivery system <NUM> may be used to deliver and deploy heart valve <NUM> in native valve annulus <NUM>, and may generally include sheath <NUM>, core <NUM>, atraumatic tip <NUM> and hub <NUM>. Sheath <NUM> may be slidable relative to core <NUM>. Heart valve <NUM>, including stent <NUM>, valve assembly <NUM>, legs <NUM> and sealing portion <NUM>, may be disposed within sheath <NUM> about core <NUM> (<FIG>). Hub <NUM> may be coupled to core <NUM> and configured to mate with retaining elements <NUM> of heart valve <NUM>. Elongated legs <NUM> of heart valve <NUM> may be disposed in the extended configuration of <FIG>, substantially parallel to sheath <NUM>, during delivery. Specifically, though legs <NUM> are configured to return to their relaxed configuration by curling outwardly, they may be kept substantially linear by being constrained within sheath <NUM>. By doing so, sealing portion <NUM> and legs <NUM> may be delivered to the native valve annulus using delivery system <NUM> without increasing the radius of sheath <NUM>, avoiding the need to increase the crimp profile of the heart valve within delivery system <NUM>. A large delivery system may be incapable of being passed through the patient's vasculature, while a delivery system having a heart valve with a smaller crimp profile may be easier to navigate through a patient's body and may also reduce the operation time. In the example shown in <FIG>, delivery system <NUM> is delivered from the aorta toward the left ventricle as indicated by arrow S1. If heart valve <NUM> or delivery system <NUM> includes echogenic materials, such materials may be used to guide delivery system <NUM> to the appropriate position using the assistance of three-dimensional echocaradiography to visualize heart valve <NUM> within the patient. Alternative visualization techniques known in the art are also contemplated herein.

When delivery system <NUM> has reached the proper location (e.g. atraumatic tip <NUM> is just past native valve annulus <NUM>), atraumatic tip <NUM> may be advanced slightly in the direction of arrow S1 toward the left ventricle by pushing core <NUM> toward atraumatic tip <NUM> while holding sheath <NUM> in place which serves to decouple atraumatic tip <NUM> from sheath <NUM> (<FIG>). Sheath <NUM> may then be retracted in the direction of arrow S2 toward the aorta. As seen in <FIG>, with sheath <NUM> slightly retracted, legs <NUM> begin to emerge from the sheath and return to their relaxed configuration by curling outwardly with sealing portion <NUM>, which is attached thereto, curling along with legs <NUM>. As sheath <NUM> is further retracted in the direction of arrow S2, more of each leg <NUM> is exposed and curls upon itself (<FIG>) until legs <NUM> fully return to their relaxed configuration (<FIG>). Sealing portion <NUM> attached to curled legs <NUM> forms sealing ring <NUM>. At this juncture, stent <NUM> is still disposed within sheath <NUM> and heart valve <NUM> has not yet begun to expand. Sheath <NUM> may be retracted further until heart valve <NUM> is free to selfexpand within native valve annulus <NUM>. While heart valve <NUM> is partially deployed (e.g., a portion of heart valve <NUM> is outside sheath <NUM>, but heart valve <NUM> is not fully detached from delivery system <NUM>), if it appears that heart valve <NUM> needs to be recaptured and redeployed due to, for example, improper positioning or orientation, sheath <NUM> may be slid over core <NUM> in the direction of arrow S1 to recapture heart valve <NUM> within sheath <NUM>. During recapture, sheath <NUM> may push against legs <NUM> to straighten them to the extended configuration shown in <FIG>. This process may be repeated until heart valve <NUM> is properly positioned and deployed within native valve annulus <NUM>. After sheath <NUM> has been fully retracted to expose heart valve <NUM>, sealing ring <NUM>, being disposed at proximal end <NUM> of heart valve <NUM>, may occlude gaps <NUM> between heart valve <NUM> and native valve annulus <NUM>, thereby reducing or eliminating the amount of blood that passes around heart valve <NUM> through gaps <NUM> (<FIG>). Retaining elements <NUM> of heart valve <NUM> may be decoupled from hub <NUM> and delivery system <NUM>, including atraumatic tip <NUM>, may then be retracted through heart valve <NUM> in the direction of arrow S2 and removed from the patient.

<FIG> are enlarged schematic partial side views showing heart valve <NUM> having legs in an extended configuration and in a relaxed configuration, respectively. Heart valve <NUM> extends between proximal end <NUM> and a distal end (not shown) and generally includes stent <NUM> and a valve assembly (not shown for the sake of clarity) having a cuff and leaflets similar to those described above with reference to <FIG>. Heart valve <NUM> further includes elongated legs <NUM> and sealing portion <NUM> attached to elongated legs <NUM> at eyelets <NUM> via sutures. These elements may be formed of any of the materials described above with reference to <FIG>. Legs <NUM> may be attached to or formed integrally with stent <NUM> at attachment ends <NUM> to couple legs <NUM> to stent <NUM>. As seen in <FIG>, legs <NUM> may be attached to stent <NUM> at eyelets <NUM> near the proximal end <NUM> of heart valve <NUM> at the top of the second row of cells <NUM> of stent <NUM>, and in their extended configuration, may extend substantially linearly toward the distal end of the valve, terminating at free ends <NUM>.

<FIG> illustrates the relaxed configuration of legs <NUM>. Legs <NUM> may be biased so that, when they return to their relaxed configuration, legs <NUM> curl down toward the proximal end <NUM> of the valve, as shown in <FIG>. Due to the coupling of sealing portion <NUM> to legs <NUM>, the curling of legs <NUM> results in a similar curling of sealing portion <NUM>, causing it to roll down in the process to form upper sealing ring <NUM> within annulus portion <NUM> of heart valve <NUM>. Upper sealing ring <NUM> may have a radius larger than that of the valve assembly, and therefore may be capable of filling any gaps between heart valve <NUM> and the native valve annulus (not shown). As shown in <FIG>, sealing ring <NUM> is spaced from proximal end <NUM> and may be useful for intra-leaflet applications that are described below with reference to <FIG>. In at least some examples, sealing ring <NUM> may be positioned within annulus portion <NUM> so as to be directly radially outward of the leaflets of heart valve <NUM> (not shown). Heart valve <NUM> may be disposed within a delivery system, delivered to the native valve annulus and deployed therein using a delivery system that is the same as or similar to that described in <FIG>.

Alternatively, legs <NUM> may be attached to stent <NUM> at eyelets <NUM> and, in the extended condition, may extend substantially linearly toward the proximal end <NUM> of heart valve <NUM> so that free ends <NUM> are closer to proximal end <NUM> than attachment ends <NUM>. In this alternative example, legs <NUM> may curl upward toward the distal end to form sealing ring <NUM>. Thus, the location of attachment ends <NUM> and the direction of the curling of legs <NUM> may be used to vary the position of sealing ring <NUM> with respect to heart valve <NUM>.

<FIG> is an enlarged schematic partial side view showing an alternate extended configuration of the elongated legs. Heart valve 500C extends between proximal end 502C and a distal end (not shown) and generally includes stent 506C and a valve assembly (not shown for the sake of clarity) having a cuff and leaflets similar to those described above with reference to <FIG>. Heart valve 500C further includes elongated legs 520C and sealing portion 522C attached to elongated legs 520C. These elements may be formed of any of the materials described above with reference to <FIG>. Legs 520C may be attached to or formed integrally with stent 506C at attachment ends 525C to couple legs 520C to stent 506C. Specifically, legs 520C may be coupled to one or more struts 541C, which form cells 542C or a portion of a cell. Though the previous embodiments have shown attachment ends 525C as being attached to or originating from an intersection of two struts 541C, attachment ends 525C may be coupled to or formed integrally with only one strut 541C. In this example, four struts 541C forming the four sides of cell 542C intersect at four corners of cell 542C, and attachment ends 525C are coupled to a single strut 541C approximately halfway between corners of cell 542C. It will be understood, however, that elongated legs 520C may be coupled to any portion of stent 506C and/or at any location along struts 541C and/or any number of struts. Elongated legs 520C may curl in the same manner described above from a relaxed configuration to form a sealing ring.

<FIG> are schematic side views of another embodiment, showing heart valve <NUM> having legs in an extended configuration and a relaxed configuration, respectively. Heart valve <NUM> extends between proximal end <NUM> and a distal end (not shown) and generally includes stent <NUM> and a valve assembly (not shown for the sake of clarity) having a cuff and leaflets similar to those described above with reference to <FIG>. Heart valve <NUM> further includes first elongated legs <NUM> and first sealing portion <NUM>, which may be attached to first elongated legs <NUM> at eyelets <NUM> via sutures. In a configuration similar to that described above with reference to <FIG>, first legs <NUM> may be attached to or formed integrally with stent <NUM> at attachment ends <NUM> near the proximal end <NUM> of heart valve <NUM>, and may extend substantially linearly toward the distal end of the valve, terminating at free ends <NUM>. Heart valve <NUM> further includes second elongated legs <NUM> attached to stent <NUM> at second attachment ends <NUM>, which are located at proximal end <NUM> of the valve, and, in the extended condition, legs <NUM> extend substantially linearly away from the distal end of the valve to terminate at second free ends <NUM> beyond proximal end <NUM> of heart valve <NUM>. A second sealing portion <NUM>, similar to the sealing portion described above in connection with <FIG>, may be attached to legs <NUM>.

<FIG> illustrates the relaxed configuration of the legs of heart valve <NUM>. First legs <NUM> may be biased so that, when they return to their relaxed configuration, they curl down toward the proximal end <NUM> of the valve, as shown in <FIG>. Due to the coupling of first sealing portion <NUM> to first legs <NUM>, the curling of first legs <NUM> results in a similar curling of first sealing portion <NUM>, causing it to roll down in the process to form upper sealing ring <NUM> within annulus portion <NUM> of heart valve <NUM> (e.g. forming a ring at an intra-leaflet position). Likewise, when secondary legs <NUM> return to their relaxed configuration, they may curl up toward the distal end of heart valve <NUM>, pulling second sealing portion <NUM> with them to form lower sealing ring <NUM> (e.g. forming a ring at a sub-leaflet position). When heart valve <NUM> is implanted using a delivery system similar to that shown in <FIG>, lower sealing ring <NUM> may take shape first as the outer sheath of the delivery system is retracted, followed by upper sealing ring <NUM>. Additional methods may be used to actuate the formation of either of the sealing rings regardless of the delivery approach.

<FIG> illustrate several additional variants of a heart valve having sealing portions according to the present disclosure. In <FIG>, heart valve 700A extends between proximal end <NUM> and a distal end (not shown) and generally includes stent <NUM> and a valve assembly (not shown) having a cuff and leaflets. Heart valve 700A further includes elongated legs <NUM> coupled to stent <NUM> near proximal end <NUM>, which legs <NUM>, in their extended configuration, may extend substantially linearly away from the distal end of the valve. A sealing portion <NUM> is coupled to legs <NUM>. In order to provide a more secure attachment of sealing portion <NUM> to legs <NUM>, each leg <NUM> may include multiple eyelets 724A-D along its length and sealing portion <NUM> may be coupled to legs <NUM> at each of the eyelets. Eyelets 724A-D may be uniformly distributed along the length of each leg <NUM>, as seen in <FIG>, resulting in better coupling of sealing portion <NUM> to legs <NUM> and a more uniform curling of sealing portion <NUM> in the formation of a sealing ring.

Although the elongated legs in all of the embodiments described above have had a substantially linear configuration in the extended configuration, they may be formed with other configurations. <FIG> illustrates a heart valve 700B having nonlinear elongated legs. Heart valve 700B extends between proximal end <NUM> and a distal end (not shown) and includes stent <NUM> and a valve assembly having a cuff and leaflets as described above. Heart valve 700B includes elongated legs 720B that are curved or wavy in their extended configuration in contrast to the substantially linear legs of the previous embodiments. Wavy legs 720B may couple to stent <NUM> at proximal end <NUM> of heart valve 700B and extend away from the distal end thereof. Legs 720B may be formed to curl in their relaxed configuration in a manner similar to the elongated legs described above. A sealing portion 722B may be attached to legs 720B so as to form a sealing ring in the relaxed configuration of the legs.

In <FIG>, another example is shown in which heart valve 700C extends between a proximal end <NUM> and a distal end (not shown) and includes stent <NUM> and pairs of elongated legs 720C, 720D. Heart valve 700C further includes a valve assembly having a cuff and leaflets and a sealing portion (none of which are shown for the sake of clarity). In the extended configuration of the legs, shown in <FIG>, legs 720C, 720D are formed in pairs that originate at a common attachment end <NUM> at the apex of a cell at proximal end <NUM> and extend away from the distal end of heart valve 700C in substantially linear configurations to terminate in independent free ends <NUM>. As shown in their relaxed configuration in <FIG>, legs 720C, 720D may curl upward toward the distal end of heart valve 700C along with the attached sealing portion, as previously described, to form a sealing ring. This configuration may provide additional structure for forming and supporting the sealing ring.

As will be appreciated from the embodiments described above, the elongated legs may be attached at the proximal end of a heart valve or anywhere in the annulus portion of the valve. Additionally, in their extended configuration, the elongated legs may extend either toward or away from the distal end of the heart valve, and in their relaxed configuration, may curl in either direction. By varying the points of attachment and the orientation of the elongated legs, sealing rings may be formed at different locations along the valve. In some applications, damaged or calcified native valve leaflets may not be resected prior to implantation of a prosthetic heart valve. The location of the sealing rings may be modified to accommodate the unresected native valve leaflets.

<FIG> illustrate heart valves 800A-C disposed within a native valve annulus adjacent unresected native leaflets <NUM>. In <FIG>, heart valve 800A includes sealing ring 850A at a proximal end thereof and configured to be disposed below native leaflets <NUM> (i.e., sub-leaflet location). Sealing ring 850A may be at least partially disposed below native leaflets <NUM> and may contact the native leaflets to provide a seal between heart valve 800A and native leaflets <NUM>. <FIG> illustrates heart valve 800B having a sealing ring 850B spaced distally of the proximal end of the valve and configured to be disposed within native leaflets <NUM> to provide a seal between heart valve 800B and native leaflets <NUM> (i.e., intra-leaflet location). <FIG> illustrates a heart valve 800C having a sealing ring 850C spaced further distally of the proximal end of the valve and configured to be disposed above the free edges of native leaflets <NUM> to provide a seal between heart valve 800C and native leaflets <NUM> (i.e., supra-leaflet location). Thus, sealing rings 850A-C may be disposed at various locations relative to native leaflets <NUM>. It will be appreciated that combinations of any of these sealing rings may be possible. For example, a heart valve may include two sealing rings, a first sealing ring 850A configured to be disposed below native leaflets <NUM>, and a second sealing ring 850C configured to be disposed above the free edges of native leaflets <NUM>. When sealing ring 850A is disposed below the native valve leaflets <NUM> (<FIG>), it may prevent heart valve 800A from migrating into the aorta. When sealing ring 850C is disposed above the native valve leaflets (<FIG>), it may prevent heart valve 800C from migrating into the left ventricle. Thus, with this and similar configurations, sealing rings may be used to anchor a heart valve in the native valve annulus, thereby preventing the heart valve from migrating from its intended position.

<FIG> illustrate another embodiment of heart valve <NUM> having sealing features to mitigate perivalvular leakage. Heart valve <NUM> of <FIG> extends between proximal end <NUM> and a distal end (not shown) and includes a stent <NUM>, a valve assembly (not shown) including a cuff and leaflets, and elongated legs <NUM>. Legs <NUM> may be attached to stent <NUM> at attachment ends <NUM> near the proximal end <NUM> of heart valve <NUM> and, in the extended configuration of the legs shown in <FIG>, may extend substantially linearly away from the distal end of the valve, terminating in free ends <NUM>. A sealing portion <NUM> may be attached to legs <NUM> in the same manner as the sealing portions described above. When legs <NUM> of heart valve <NUM> return to their relaxed configuration, instead of curling over themselves as shown in the previous embodiments, they may axially collapse to form an undulating shape, as seen in <FIG>. As a result of this collapse, portions of legs <NUM> may billow radially out from the profile of the annulus portion <NUM> of heart valve <NUM> by an additional distance d<NUM> to form distended portion <NUM>. As shown in <FIG>, multiple distended portions <NUM> may be formed. Each distended portion <NUM> may extend circumferentially to form a sealing ring <NUM> or a portion of a sealing ring.

<FIG> illustrates a first example of an elongated leg 920C that is capable of collapsing axially to form distended portion <NUM>. In this first example, leg 920C may be substantially linear and have a first length L1 in an extended configuration. Leg 920C may be heat set or otherwise configured to axially collapse to an undulating shape 920C' having a shorter length L2 in the relaxed configuration. When leg 920C assumes undulating shape 920C' it will not only shorten, but will also form convex regions 930C along its length that collectively define distended portions <NUM> of sealing ring <NUM>. <FIG> illustrates another example in which an elongated leg 920D having a length L1 in an extended configuration shortens to an N-shape 920D' having a length L3 in the relaxed configuration. Legs 920D form convex regions 930D along their lengths that collectively define distended portions <NUM> of heart valve <NUM>. It will be understood that <FIG> illustrate only two possible examples for forming distended portion <NUM> and that various techniques and shapes may be used to alternate between a substantially linear elongated leg in the extended configuration and a shortened shape having convex regions in the relaxed configuration.

<FIG> illustrate example of a heart valve <NUM>, not falling within the scope of the claims. Heart valve <NUM> extends between proximal end <NUM> and distal end <NUM>, and may generally include stent <NUM> and valve assembly <NUM> having a plurality of leaflets <NUM> and cuff <NUM>. Additionally, heart valve <NUM> may include a number of elongated legs <NUM> and a sealing portion <NUM> coupled to the elongated legs via eyelets <NUM> to mitigate perivalvular leakage. Legs <NUM> may be formed of a shape memory material such as those described above with reference to <FIG> and may have an extended configuration and a relaxed configuration. Attachment ends <NUM> of elongated legs <NUM> may be affixed to stent <NUM> near proximal end <NUM> of heart valve <NUM>, and legs <NUM> may extend away from the distal end <NUM> of stent <NUM> and terminate at eyelets <NUM>. In this example, sealing portion <NUM> may be in the form of a generally toroidal-shaped sealing ring <NUM>, regardless of whether legs <NUM> are in their extended or relaxed configuration. As used herein, the terms "toroid" and "toroidal" are not limited to a circle revolved about an axis external to the circle which is parallel to the plane of the figure and does not intersect the figure, but also include the revolving of other plane geometrical figures such as, for example, an oval, a triangle, a square and the like. Sealing ring <NUM> may be formed of a braided fabric comprising a plurality of braided strands, although it will be understood that any of the other materials described above with reference to <FIG> may be used as well. In the extended configuration of legs <NUM>, sealing ring <NUM> may be spaced away from proximal end <NUM> by the length of the legs.

As noted above, legs <NUM> may have an extended configuration and a relaxed configuration. <FIG> illustrates the relaxed configuration. When legs <NUM> of heart valve <NUM> are permitted to return to their relaxed configuration, legs <NUM> may curl up toward distal end <NUM> and pull sealing ring <NUM> over proximal end <NUM> of heart valve <NUM> so that sealing ring <NUM> is at least partially disposed over valve assembly <NUM> and/or cuff <NUM>. Sealing ring <NUM> may have a radius larger than that of valve assembly <NUM>, the larger radius of sealing ring <NUM> being capable of filling any gaps between heart valve <NUM> and the native valve annulus (not shown). Thus, in this embodiment, sealing ring <NUM> is already formed in both the extended and relaxed configurations of legs <NUM>, but is brought into place for sealing when legs <NUM> curl upward in the relaxed configuration.

<FIG> illustrate the extended configuration of legs <NUM> and two examples of the relaxed configuration of legs <NUM>. As seen in <FIG>, in the extended configuration, legs <NUM> are coupled to stent <NUM> of heart valve <NUM> near proximal end <NUM> and are substantially linear between eyelets <NUM> and attachment ends <NUM>. In one example shown in <FIG>, elongated legs <NUM> are configured to curl toward the distal end (not shown) of heart valve <NUM>, each elongated leg <NUM> being bent straight back so as to lie in a single plane Z. Alternatively, as shown in <FIG>, each elongated leg <NUM> may also be bent with respect to the plane of attachment Z such that it ends in a second plane Z' which forms an angle α with respect to plane of attachment Z. The angle between the two planes may be between about <NUM> degree and about <NUM> degrees. By bending leg <NUM> in such a manner, leg <NUM> may be more conformable, aiding in the transition between the extended and the relaxed configurations.

<FIG> is an enlarged partial perspective view showing the bending of the elongated legs of heart valve 1000F. Heart valve 1000F may extend between proximal end 1002F and a distal end (not shown) and includes stent 1006F and elongated legs 1020F, each having an eyelet 1024F. Elongated legs 1020F may be coupled to stent 1006F at attachment ends 1025F. It may be difficult to bend elongated legs 1020F due to the thickness and width of the legs. Elongated legs 1020F therefore may be twisted along their longitudinal axis in order to more easily bend the legs. In addition to twisting, elongated legs 1020F may be bent as shown above with reference to <FIG>. The twisting and bending of elongated legs <NUM> may weaken the leg so that a desired stiffness is achieved for proper extension and relaxation of the legs.

<FIG> are highly schematic partial side views of heart valves, showing variations in how the elongated legs are bent in the relaxed configuration. In a first example, heart valve 1100A includes stent <NUM> and elongated legs 1120A coupled thereto (<FIG>). Elongated legs 1120A of heart valve 1100A bend in the shape of a semicircle, and sealing portion 1122A, which is attached to elongated legs 1120A, curls with elongated legs 1120A to form sealing ring 1150A in the shape of a semicircle revolved about an axis external to the semicircle which is parallel to the plane of the figure and does not intersect the figure. In a second example, heart valve 1100B includes stent <NUM> and elongated legs 1120B coupled thereto (<FIG>). Elongated legs 1120B of heart valve 1100B bend to form an almost complete circle, and sealing portion 1122B, which is attached to elongated legs 1120B, curls with elongated legs 1120B to form sealing ring 1150B in the shape of an ellipsoid revolved in the manner described above. <FIG> illustrates another example in which heart valve 1100C includes stent <NUM> and elongated legs 1120C, which bend in multiple curls to stretch sealing portion 1122C to form a spiral-shaped sealing ring 1150C in the shape of a revolved curl. It will be understood from these examples that the elongated legs may include any number of curls or portions of curls.

Moreover, the elongated legs may take a number of shapes other than curls. For example, in <FIG>, heart valve 1100D includes elongated legs 1120D coupled to stent <NUM>. Elongated legs 1120D are configured to bend in the shape of a triangle as shown, sealing portion 1122D bending with them to form sealing ring 1150D in the shape of a revolved triangle. <FIG> illustrates another example of heart valve 1100E having elongated legs 1120E coupled to stent <NUM>. Elongated legs 1120E curl in a substantially elliptical shape having a major axis m1 disposed at an upward angle β1 with respect to an axis x extending in the radial direction of heart valve 1100E. In this example, major axis m1 forms an upward angle β1 of about <NUM> degrees with respect to axis x, causing sealing portion 1122E to form sealing ring 1150E in the shape of a distally-pointing revolved ellipsoid. In an alternative configuration, elongated legs 1120F may be coupled to stent <NUM> of heart valve 1100F as shown in <FIG>. Elongated legs 1120F curl in a substantially elliptical shape as in <FIG>, the ellipse having a major axis m2 disposed at a downward angle β2 with respect to an axis x extending in the radial direction of heart valve 1100F. In this example, major axis m2 forms a downward angle β2 of about <NUM> degrees with respect to axis x, causing sealing portion 1122F to form sealing ring 1150F in the shape of a proximally-pointing revolved ellipsoid. It will be understood that various modifications may be made to any of these basic shapes of the elongated legs. For example, the foregoing shapes may be inverted when the elongated legs extend toward the distal end of a heart valve (e.g., a triangle that is inverted from that shown in <FIG>). Thus, the elongated legs may take any desired shape to form sealing rings of various profiles and radiuses to adequately seal the region between the heart valve and the native valve annulus.

<FIG> illustrate another exemplary heart valve <NUM>. Heart valve <NUM> extends between proximal end <NUM> and distal end <NUM>, and may generally include stent <NUM> and valve assembly <NUM> having a plurality of leaflets <NUM> and a cuff <NUM>. Additionally, heart valve <NUM> may include a number of elongated legs <NUM> and sealing clusters <NUM> coupled to the elongated legs via eyelets <NUM> to mitigate perivalvular leakage. Elongated legs <NUM> may be formed of a shape memory material such as those described above with reference to <FIG> and may have an extended configuration and a relaxed configuration. Attachment ends <NUM> of elongated legs <NUM> may be affixed to stent <NUM> near proximal end <NUM> of heart valve <NUM>, and legs <NUM> may extend away from the distal end <NUM> of stent <NUM> and terminate at eyelets <NUM> to which sealing clusters <NUM> are attached. In this example, sealing clusters <NUM> may be formed of a braided fabric formed in a three-dimensional body comprising a plurality of braided strands of nitinol, although it will be understood that any of the other materials described above with reference to <FIG> may be used as well. As shown in <FIG>, in the extended configuration, elongated legs <NUM> are substantially linear and sealing clusters <NUM> are disposed below valve assembly <NUM> so as not to add bulk when collapsed inside a delivery device.

As noted above, elongated legs <NUM> may have an extended configuration and a relaxed configuration. <FIG> illustrates the relaxed configuration. When legs <NUM> are permitted to return to their relaxed configuration, they may curl up toward distal end <NUM>, pulling sealing clusters <NUM> into position between heart valve <NUM> and the native valve annulus (not shown). Sealing clusters <NUM> may be moved independently of one another to fill any gaps between heart valve <NUM> and the native valve annulus.

Additionally, sealing clusters <NUM> may take any number of shapes and may be attached to elongated legs <NUM> via eyelets <NUM> as shown in <FIG>. For example, <FIG> illustrates a globular sealing cluster 1222C having a flowershaped longitudinal cross-section. <FIG> illustrates sealing cluster 1222D having a hemispherical shape with a semicircular longitudinal cross-section. <FIG> illustrates sealing cluster 1222E having a spherical shape with a circular longitudinal cross-section. <FIG> illustrates sealing cluster 1222F having an ellipsoid shape with an elliptical longitudinal cross-section. <FIG> illustrates sealing cluster <NUM> having a cylindrical shape with a rectangular longitudinal cross-section, and <FIG> illustrates sealing cluster <NUM> having a shorter cylindrical shape with a substantially square longitudinal cross-section. Thus, the shape, size and number of sealing clusters <NUM> may be varied as desired. In addition, a combination of sealing clusters <NUM> having different shapes and sizes may also be used (e.g., a single heart valve <NUM> having both spherical sealing clusters 1222E and cylindrical sealing clusters <NUM>). Multiple clusters <NUM> may also be coupled to each elongated leg <NUM>. Additionally, the spacing of the sealing clusters may be varied such that sealing clusters <NUM> are spaced away from one another or made to overlap with one another. Moreover, the lengths of legs <NUM> may be selected to create a larger sealing zone at various locations with respect to the native valve leaflets. For example, shorter legs <NUM> may form sub-leaflet sealing zones while longer legs may form a supra-leaflet sealing zones.

<FIG> is a highly schematic cross-sectional view showing heart valve <NUM> having stent <NUM>, valve assembly <NUM> including a cuff (not shown) and leaflets <NUM>, and elongated legs <NUM> supporting a sealing portion <NUM>. Legs <NUM> have curled up to form sealing ring <NUM> and heart valve <NUM> has been disposed within native valve annulus <NUM>. As seen in <FIG>, sealing ring <NUM> has radially expanded to fill gaps <NUM> shown in <FIG>, and may be capable of promoting tissue growth between heart valve <NUM> and native valve annulus <NUM>. For example, sealing portion <NUM> may be innately capable or promoting tissue growth and/or treated with a biological or chemical agent to promote tissue growth, further enabling sealing ring <NUM>, when expanded, to seal the heart valve within the native valve annulus. Alternatively, the expanded sealing ring <NUM> may be sufficiently dense to adequately seal around heart valve <NUM> without the need for major tissue growth. Sealing portion <NUM> may also be double-layered and in embodiments having a mesh sealing portion, it may include tighter braiding to more completely occlude the space between heart valve <NUM> and native valve annulus <NUM>. When sealing ring <NUM> is functioning properly, heart valve <NUM> will be adequately sealed within native valve annulus <NUM> so that blood flows through leaflets <NUM> of valve assembly <NUM>, and so that blood flow through any gaps formed between heart valve <NUM> and native valve annulus <NUM> is limited or reduced.

While the inventions herein have been described for use in connection with heart valve stents having a particular shape, the stent could have different shapes, such as a flared or conical annulus section, a less-bulbous aortic section, and the like, as well as a differently shaped transition section. Moreover, though the elongated legs have been described as having an attachment end and a free end, the elongated legs may be attached to the stent at both ends and exhibit a linear array extended configuration when disposed within a delivery system. The elongated legs may radially expand to form a sealing ring in the relaxed configuration when deployed from the delivery system. Additionally, though the sealing rings have been described in connection with expandable transcatheter aortic valve replacement, they may also be used in connection with other expandable cardiac valves, as well as with surgical valves, sutureless valves and other devices in which it is desirable to create a seal between the periphery of the device and the adjacent body tissue.

The disclosure herein includes a prosthetic heart valve for replacing a native valve comprising a collapsible and expandable stent having a proximal end and a distal end, a valve assembly disposed within the stent, the valve assembly including a plurality of leaflets, a first plurality of elongated legs coupled to the stent transitionable from an extended configuration to a relaxed configuration; and a first sealing portion connected to the first plurality of legs and forming a first sealing structure upon the transition of the first plurality of legs from the extended configuration to the relaxed configuration.

In some examples, each of the plurality of legs may be substantially linear in the extended configuration. Each of the plurality of legs may be curled in the relaxed configuration. The sealing portion may curl to form a sealing ring when the plurality of legs transition from the extended configuration to the relaxed configuration. The sealing ring may be configured and arranged to be disposed below native leaflets of the native valve. The sealing ring may be configured and arranged to be disposed within native leaflets of the native valve. The sealing ring may be configured and arranged to be disposed above native leaflets of the native valve. The plurality of legs may be coupled to the proximal end of the stent and the free ends of the legs extend toward the distal end of the stent in the extended configuration.

In some additional examples, the plurality of legs may be coupled to the proximal end of the stent and the free ends of the legs may extend away from the distal end of the stent in the extended configuration. The sealing portion may include at least one of a metallic mesh or a shape-memory material. The valve assembly may further include a cuff coupled to the stent, the sealing portion and the cuff being made of the same material. The sealing portion may be formed by enlarging the cuff and extending the cuff over the plurality of legs. Each of the plurality of legs may include an eyelet for attaching the sealing portion to the leg. The plurality of legs may be arranged in pairs of legs, each pair of legs being coupled to the stent at a common attachment end. The plurality of legs may billow radially outwardly in the relaxed configuration.

In some examples, the stent may include an annulus portion having a deployed diameter and the sealing portion forms a distended portion having an expanded diameter when the plurality of legs billow radially outwardly in the relaxed configuration, the expanded diameter being larger than the deployed diameter. In some examples, a delivery system for use with the heart valve may include a core and a sheath disposed about the core, the heart valve being disposed about the core and within the sheath.

Moreover, although the inventions herein have been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the scope of the present inventions as defined by the appended claims.

Claim 1:
A prosthetic heart valve (<NUM>) for replacing a native valve, comprising:
a collapsible and expandable stent (<NUM>) extending between a proximal end (<NUM>) and a distal end (<NUM>);
a valve assembly (<NUM>) disposed within the stent, the valve assembly including a plurality of leaflets (<NUM>);
a first plurality of elongated legs (<NUM>) integrally formed with the stent and transitionable from an extended configuration to a relaxed configuration and having free ends (<NUM>), the first plurality of elongated legs (<NUM>) being coupled to the proximal end of the stent, each of the plurality of elongated legs having a free end extending away from the distal end of the stent in the extended configuration, and
wherein the prosthetic heart valve further comprises a first sealing portion (<NUM>) connected to the first plurality of legs and forming a first sealing structure upon the transition of the first plurality of legs from the extended configuration to the relaxed configuration, wherein the sealing portion (<NUM>) extends from a first end at the stent where the first plurality of elongated legs (<NUM>) are attached to the stent to a second end at the free ends (<NUM>), wherein each of the first plurality of legs is curled in the relaxed configuration, wherein the first sealing portion curls to form a sealing ring (<NUM>) when the first plurality of legs transition from the extended configuration to the relaxed configuration, wherein the prosthetic valve is configured and arranged to be disposed in an annulus of the native valve in a deployed condition, and the first sealing ring is at the proximal end and configured to be disposed below leaflets of the native valve in the deployed condition.